Welcome to the international HTA database

Showing [23806 Records] Selected Records [0 Hits] [Clear]

Year	Source	Title
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Brain electrical activity mapping for diagnosing psychiatric disorders: a review of the clinical evidence
2014	German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI)	[Systematic guideline search and appraisal, as well as extraction of relevant recommendations, for the DMP "asthma"]
2014	HAYES, Inc.	PTEN gene expression testing in Non-Small Cell Lung Cancer (NSCLC)
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Rivaroxaban (Xarelto- Bayer Inc.) new Indication: pulmonary embolism
2014	Agency for Healthcare Research and Quality (AHRQ)	Therapies for children with autism spectrum disorder: behavioral interventions update
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Aripiprazole for pregnant women: safety
2014	HAYES, Inc.	Von Hippel-Lindau (VHL) syndrome
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Golimumab (Simponi - Janssen Inc.) new indication: ulcerative colitis
2014	Agency for Healthcare Research and Quality (AHRQ)	Cardiac troponins used as diagnostic and prognostic tests in patients with kidney disease
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Neuro-linguistic programming for the treatment of adults with post-traumatic stress disorder, general anxiety disorder, or depression: a review of clinical effectiveness and guidelines
2014	HAYES, Inc.	Apnea Risk Evaluation System (ARES; Watermark Medical Inc.) for diagnosis of obstructive sleep apnea
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Nebulizers for the methacholine challenge test: diagnostic accuracy and guidelines
2014	Institut national d'excellence en sante et en services sociaux (INESSS)	[Stereotactic ablative radiation therapy for the treatment of non-small cell lung cancer]
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Locked units to limit access for dementia patients in long-term care facilities: clinical evidence
2014	HAYES, Inc.	ATI neurostimulation system (Autonomic Technologies Inc.) for electrical stimulation of the Sphenopalatine Ganglion (SPG) for headache
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Intra-aortic balloon pumps for cardiac conditions: guidelines
2014	Institut national d'excellence en sante et en services sociaux (INESSS)	[Digital Breast Tomosynthesis]
2014	Medical Services Advisory Committee (MSAC)	Insertion of subcutaneous electrode for the purpose of use with an implantable cardioverter defibrillator (ICD)
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Transcranial magnetic stimulation for the treatment of adults with PTSD, GAD, or depression: a review of clinical effectiveness and guidelines
2014	HAYES, Inc.	Catalys precision laser system (OptiMedica Corp.; Abbott Medical Optics) for cataract surgery
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Sterilization of gauze for surgical procedures: clinical effectiveness, harms, and guidelines
2014	Institut national d'excellence en sante et en services sociaux (INESSS)	[Effectiveness and safety of single-use protective sheaths for flexible nasopharyngolaryngoscopes]
2014	Medical Services Advisory Committee (MSAC)	Ocriplasmin for symptomatic vitreomacular adhesion (sVMA) including macular hole
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Screening and risk stratification for diabetic foot ulcers: a review of clinical effectiveness, cost-effectiveness, and guidelines
2014	NIHR Health Technology Assessment programme	The design of a survey questionnaire to measure perceptions and behaviour during an influenza pandemic: the Flu TElephone Survey Template (FluTEST)
2014	HAYES, Inc.	iFuse implant system (SI-BONE Inc.) for sacroiliac joint fusion for treatment of low back pain
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Personal protection for visitors to patients on airborne precautions: clinical effectiveness and guidelines
2014	Institut national d'excellence en sante et en services sociaux (INESSS)	[Use of Fertil ProMD products in the treatment of infertility]
2014	Medical Services Advisory Committee (MSAC)	Specialist dermatology services delivered by asynchronous store and forward technology
2014	HAYES, Inc.	Inhaled nitric oxide for Acute Respiratory Distress Syndrome (ARDS) in adults
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Tocilizumab (Actemra - Hoffmann-La Roche Limited) new indication: polyarticular juvenile idiopathic arthritis
2014	Institut national d'excellence en sante et en services sociaux (INESSS)	[Lung cancer: investigation, treatment and follow-up algorithms]
2014	HAYES, Inc.	Applied behavior analysis-based interventions for autism spectrum disorder
2014	Medical Services Advisory Committee (MSAC)	Transcatheter occlusion of the left atrial appendage (LAA) for patients with non-valvular atrial fibrillation
2014	NIHR Health Technology Assessment programme	Multicentre cluster randomised trial comparing a community group exercise programme and home-based exercise with usual care for people aged 65 years and over in primary care
2014	HAYES, Inc.	Laser hair removal for prevention of pilonidal sinus recurrence
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Equipment required for medication nebulization: safety and guidelines
2014	Health Quality Ontario (HQO)	Point-of-care hemoglobin A1c testing: an evidence-based analysis
2014	HAYES, Inc.	Artificial disc replacement for cervical degenerative disc disease
2014	Medical Services Advisory Committee (MSAC)	Second Opinion for Morphological/Interpretive Pathology
2014	HAYES, Inc.	Magnetic Resonance-guided Focused Ultrasound (MRgFUS) therapy (ExAblate; InSightec Ltd.) for ablation of uterine fibroids
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Fall prevention strategies for adults in outpatient programs: clinical evidence and guidelines
2014	Health Quality Ontario (HQO)	Point-of-care hemoglobin A1c testing: a budget impact analysis
2014	HAYES, Inc.	Choline PET and PET-CT for suspected recurrent prostate cancer
2014	Medical Services Advisory Committee (MSAC)	Bone mineral density analyses using Dual Energy X-Ray Absorptiometry (DXA) in breast cancer patients receiving aromatase inhibitor treatment
2014	HAYES, Inc.	Negative pressure wound therapy after fasciotomy
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Mobile apps for improving health: clinical evidence
2014	Health Quality Ontario (HQO)	Optical coherence tomography monitoring strategies for A-VEGF–treated age-related macular degeneration: an evidence-based analysis
2014	HAYES, Inc.	Computer-aided detection (CAD) with full-field digital mammography (FFDM) for breast cancer screening
2014	Medical Services Advisory Committee (MSAC)	The removal of imbedded corneal foreign bodies by an optometrist
2014	HAYES, Inc.	Nonpulsed (Thermal) percutaneous Radiofrequency Ablation (RFA) for treatment of cervicogenic headache
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Eplerenone (Inspra - Pfizer Canada Inc.) new indication: NYHA class II heart failure
2014	Health Quality Ontario (HQO)	Point-of-care hemoglobin A1c testing: OHTAC recommendation
2014	HAYES, Inc.	Digital breast tomosynthesis for breast cancer diagnosis and screening
2014	Medical Services Advisory Committee (MSAC)	Repetitive Transcranial Magnetic Stimulation (rTMS) for the treatment of depression
2014	Canary Health Service	[Cost-effectiveness of neonatal screening for very long chain acyl-CoA dehydrogenase deficiency (VLCADD)]
2014	HAYES, Inc.	Open surgery for sacroiliac joint fusion for the treatment of low back pain
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Direct acting antivirals for chronic hepatitis C genotype 1 in select populations: emerging evidence of clinical effectiveness and safety
2014	Health Quality Ontario (HQO)	Hemoglobin A1c testing in diabetes: OHTAC recommendation
2014	HAYES, Inc.	Electrical spinal cord stimulation for the treatment of intractable angina pectoris
2014	Medical Services Advisory Committee (MSAC)	Non-mydriatic retinal photography (NMP) in persons with diabetes
2014	Canary Health Service	[Cost-effectiveness of neonatal screening for primary carnitine deficiency]
2014	HAYES, Inc.	Portable pneumatic compression versus low-molecular-weight heparin for prevention of deep vein thrombosis after lower-extremity joint arthroplasty
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Closed intensive care units: clinical and cost-effectiveness, safety, and guidelines
2014	Health Quality Ontario (HQO)	Optical coherence tomography monitoring strategies for A-VEGF–treated age-related macular degeneration: OHTAC recommendation
2014	HAYES, Inc.	Extracorporeal membrane oxygenation for respiratory failure (children and adults)
2014	Medical Services Advisory Committee (MSAC)	Remote monitoring of patients with implanted cardiac devices (resubmission)
2014	Canary Health Service	[Report on insertable Holter with remote monitoring]
2014	NIHR Health Technology Assessment programme	START (STrAtegies for RelaTives) study: a pragmatic randomised controlled trial to determine the clinical effectiveness and cost-effectiveness of a manual-based coping strategy programme in promoting the mental health of carers of people with dementia
2014	HAYES, Inc.	Portable versus non-portable intermittent pneumatic compression for prevention of postoperative deep vein thrombosis
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Re-treatment with direct acting antivirals for chronic hepatitis C genotype 1: emerging evidence of clinical effectiveness and safety
2014	HAYES, Inc.	High-resolution anoscopy for the evaluation of anal lesions
2014	Medical Services Advisory Committee (MSAC)	Diagnostic fluorescence in situ hybridisation (FISH) testing for Anaplastic Lymphoma Kinase (ALK) in advanced non-small cell lung cancer (NSCLC) to determine eligibility for crizotinib treatment (co-dependent). (Resubmission)
2014	Canary Health Service	[Urine markers for the prediction of kidney transplant rejection]
2014	HAYES, Inc.	Pronto-7 with rainbow 4D technology (Masimo Corp.) for noninvasive hemoglobin measurement
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Short-acting intramuscular olanzapine for acute agitation: clinical and cost - effectiveness and guidelines
2014	HAYES, Inc.	Minimally invasive thoracotomy for mitral valve replacement
2014	Canary Health Service	[Systematic review of aCGH for the genetic study of pediatric neurodevelopmental disorders]
2014	HAYES, Inc.	Split-night polysomnography for Continuous Positive Airway Pressure (CPAP) titration in adults with obstructive sleep apnea
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Reprocessing of single use medical devices: effectiveness, safety, and guidelines
2014	Andalusian Health Technology Assessment Area (AETSA)	[Alglucosidase alfa (Myozyme ®) in late-onset Pompe disease]
2014	HAYES, Inc.	Noninvasive peripheral arterial tonometry
2014	Canary Health Service	[Surgical treatment of benign melanocytic lesions for the prevention of melanoma]
2014	HAYES, Inc.	X stop interspinous process decompression system (Medtronic Spine LLC) for lumbar spinal stenosis
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Aspirating versus not aspirating prior to injection of medication: comparative clinical evidence and guidelines
2014	HAYES, Inc.	Palivizumab (Synagis) prophylaxis for respiratory syncytial virus infection in preterm infants
2014	Canary Health Service	[Monetary value of a quality-adjusted life year: a critical review and appraisal of the literature]
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Providing rehabilitation services for seven days versus five days per week: clinical effectiveness and guidelines
2014	HAYES, Inc.	Percutaneous tibial nerve stimulation for the treatment of lower urinary tract dysfunction
2014	NIHR Health Technology Assessment programme	Ivacaftor for the treatment of patients with cystic fibrosis and the G551D mutation: a systematic review and cost-effectiveness analysis
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	BMI reduction and chronic disease management: clinical evidence
2014	HAYES, Inc.	Preoperative physical therapy for severe osteoarthritis of the knee
2014	NIHR Health Technology Assessment programme	Allopurinol for chronic kidney disease: a systematic review
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Suspended ceiling lifts: safety
2014	HAYES, Inc.	Radioactive yttrium-90 microspheres for treatment of primary unresectable liver cancer
2014	NIHR Health Technology Assessment programme	Probiotics for antibiotic-associated diarrhoea (PAAD): a prospective observational study of antibiotic-associated diarrhoea (including Clostridium difficile-associated diarrhoea) in care homes
2014	NIHR Health Technology Assessment programme	The clinical effectiveness and cost-effectiveness of peginterferon alfa and ribavirin for the treatment of chronic hepatitis C in children and young people: a systematic review and economic evaluation
2014	NIHR Health Technology Assessment programme	Dabrafenib for treating unresectable, advanced or metastatic BRAFV600 mutation-positive melanoma (ID605)
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Suctioning for respiratory blockage: clinical effectiveness and guidelines
2014	HAYES, Inc.	Radioactive yttrium-90 microspheres for treatment of primary unresectable liver cancer as a bridge to transplantation or surgery